VIM and neoplasm: Immunostaining of tumor tissue sections from lung biopsies showed weak positive signals for PIM1, p-GSK3β (Ser9), and Vimentin before treatment, which subsequently became strong positive signals upon development of acquired osimertinib resistance (Fig. 7B, C).